Literature DB >> 20508213

Heparin-binding, hemagglutinin-specific IFN-gamma synthesis at the site of infection during active tuberculosis in humans.

Sammy Place1, Virginie Verscheure, Nour de San, Jean-Michel Hougardy, Kinda Schepers, Violette Dirix, Anne Dediste, Olivier Michel, Annie Drowart, Sabine D Allard, T Mark Doherty, Sophie Lecher, Camille Locht, Françoise Mascart.   

Abstract

RATIONALE: Tuberculosis (TB) remains a major cause of mortality. A better understanding of the immune responses to mycobacterial antigens may be helpful to develop improved vaccines and diagnostics.
OBJECTIVES: The mycobacterial antigen heparin-binding hemagglutinin (HBHA) induces strong IFN-γ responses by circulating lymphocytes from subjects latently infected with Mycobacterium tuberculosis, and low responses associated with CD4(+) regulatory T (Treg) cells in patients with TB. Here, we investigated HBHA-specific IFN-γ responses at the site of the TB disease.
METHODS: Bronchoalveolar lavages, pleural fluids, and blood were prospectively collected from 61 patients with a possible diagnosis of pulmonary or pleural TB. HBHA-specific IFN-γ production was analyzed by flow cytometry and ELISA. The suppressive effect of pleural Treg cells was investigated by depletion experiments.
MEASUREMENTS AND MAIN RESULTS: The percentages of HBHA-induced IFN-γ(+) alveolar and pleural lymphocytes were higher for pulmonary (P < 0.0001) and for pleural (P < 0.01) TB than for non-TB controls. Local CD4(+) and CD8(+) T cells produced the HBHA-specific IFN-γ. This local secretion was not suppressed by Treg lymphocytes, contrasting with previously reported data on circulating lymphocytes.
CONCLUSIONS: Patients with TB display differential effector and regulatory T-cell responses to HBHA in local and circulating lymphocytes with a predominant effector CD4(+) and CD8(+) response locally, compared with a predominant Treg response among circulating lymphocytes. These findings may be helpful for the design of new vaccines against TB, and the detection of HBHA-specific T cells at the site of the infection may be a promising tool for the rapid diagnosis of active TB.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20508213     DOI: 10.1164/rccm.201001-0083OC

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  15 in total

1.  Human lung immunity against Mycobacterium tuberculosis: insights into pathogenesis and protection.

Authors:  Stephan Schwander; Keertan Dheda
Journal:  Am J Respir Crit Care Med       Date:  2010-11-12       Impact factor: 21.405

2.  Key role of effector memory CD4+ T lymphocytes in a short-incubation heparin-binding hemagglutinin gamma interferon release assay for the detection of latent tuberculosis.

Authors:  Chloé Wyndham-Thomas; Véronique Corbière; Violette Dirix; Kaatje Smits; Fanny Domont; Myriam Libin; Marc Loyens; Camille Locht; Françoise Mascart
Journal:  Clin Vaccine Immunol       Date:  2014-01-03

3.  Comparison of two gamma interferon release assays and tuberculin skin testing for tuberculosis screening in a cohort of patients with rheumatic diseases starting anti-tumor necrosis factor therapy.

Authors:  Dimitrios Vassilopoulos; Stamatoula Tsikrika; Chrisoula Hatzara; Varvara Podia; Anna Kandili; Nikolaos Stamoulis; Emilia Hadziyannis
Journal:  Clin Vaccine Immunol       Date:  2011-10-12

4.  Highly immunoreactive antibodies against the rHup-F2 fragment (aa 63-161) of the iron-regulated HupB protein of Mycobacterium tuberculosis and its potential for the serodiagnosis of extrapulmonary and recurrent tuberculosis.

Authors:  N Sritharan; M Choudhury; S Sivakolundu; R Chaurasia; N Chouhan; P P Rao; M Sritharan
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-07-19       Impact factor: 3.267

5.  Altered expression of antigen-specific memory and regulatory T-cell subsets differentiate latent and active tuberculosis.

Authors:  Balaji Pathakumari; Santhi Devasundaram; Alamelu Raja
Journal:  Immunology       Date:  2017-11-17       Impact factor: 7.397

6.  Methylated HBHA produced in M. smegmatis discriminates between active and non-active tuberculosis disease among RD1-responders.

Authors:  Giovanni Delogu; Teresa Chiacchio; Valentina Vanini; Ornella Butera; Gilda Cuzzi; Alessandra Bua; Paola Molicotti; Stefania Zanetti; Francesco Nicola Lauria; Susanna Grisetti; Nicola Magnavita; Giovanni Fadda; Enrico Girardi; Delia Goletti
Journal:  PLoS One       Date:  2011-03-29       Impact factor: 3.240

7.  Mycobacterial Heparin-binding Hemagglutinin Antigen Activates Inflammatory Responses through PI3-K/Akt, NF-κB, and MAPK Pathways.

Authors:  Ki-Hye Kim; Chul-Su Yang; A-Rum Shin; So-Ra Jeon; Jeong-Kyu Park; Hwa-Jung Kim; Eun-Kyeong Jo
Journal:  Immune Netw       Date:  2011-04-30       Impact factor: 6.303

8.  Higher frequency of T-cell response to M. tuberculosis latency antigen Rv2628 at the site of active tuberculosis disease than in peripheral blood.

Authors:  Teresa Chiacchio; Elisa Petruccioli; Valentina Vanini; Ornella Butera; Gilda Cuzzi; Linda Petrone; Giuseppe Matteucci; Francesco Nicola Lauria; Kees L M C Franken; Enrico Girardi; Tom H M Ottenhoff; Delia Goletti
Journal:  PLoS One       Date:  2011-11-10       Impact factor: 3.240

9.  Distinct Expression Patterns of Interleukin-22 Receptor 1 on Blood Hematopoietic Cells in SARS-CoV-2 Infection.

Authors:  Nurhan Albayrak; Carmen Orte Cano; Sina Karimi; David Dogahe; Anne Van Praet; Audrey Godefroid; Véronique Del Marmol; David Grimaldi; Benjamin Bondue; Jean-Paul Van Vooren; Françoise Mascart; Véronique Corbière
Journal:  Front Immunol       Date:  2022-03-29       Impact factor: 7.561

10.  Risk stratification of latent tuberculosis defined by combined interferon gamma release assays.

Authors:  Véronique Corbière; Gaelle Pottier; Florence Bonkain; Kinda Schepers; Virginie Verscheure; Sophie Lecher; T Mark Doherty; Camille Locht; Françoise Mascart
Journal:  PLoS One       Date:  2012-08-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.